Department of Pharmacology and Therapeutics, RPCI
United States of America (USA)
1 December 2019 - 30 November 2020
Principal institution: Roswell Park Cancer Institute (RPCI)
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Department of Pharmacology and Therapeutics, RPCI published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 4 | 1.63 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 4 | 1.63 | |
Top articles by Altmetric score in current window
Pharmacological polyamine catabolism upregulation with methionine salvage pathway inhibition as an effective prostate cancer therapy
Nature Communications
2020-01-07
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma
Genome Research
2020-02-06
Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer
Nature Communications
2020-04-29
LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
Nature Communications
2019-12-02
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
